{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:36:48Z","timestamp":1792820208448,"version":"4.5.0"},"reference-count":17,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5582\/ddt.2026.01065","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:12:24Z","timestamp":1792534344000},"source":"Crossref","is-referenced-by-count":0,"title":["Patients' perceptions of hypnotic medications and factors associated with the desire to discontinue among regular users: A cross-sectional questionnaire survey in community pharmacies"],"prefix":"10.5582","author":[{"given":"Atsushi","family":"Ishimura","sequence":"first","affiliation":[{"name":"Laboratory of Clinical Pharmacy Assessment, Hoshi University, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Cosmo Pharma Co., Ltd., Fukushima, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Hoshi University, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sainokuni Higashi omiya Medical Center, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Yabuki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sainokuni Higashi omiya Medical Center, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002; 6:97-111.","DOI":"10.1053\/smrv.2002.0186"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Crowley K. Sleep and sleep disorders in older adults. Neuropsychol Rev. 2011; 21:41-53.","DOI":"10.1007\/s11065-010-9154-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Stone KL, Ensrud KE, Ancoli-Israel S. Sleep, insomnia and falls in elderly patients. Sleep Med. 2008; 9:S18-22.","DOI":"10.1016\/S1389-9457(08)70012-1"},{"key":"4","unstructured":"4. Riemann D, Espie CA, Altena E, <i>et al.<\/i> The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. J Sleep Res. 2023; 32:e14035."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Glass J, Lanct\u00f4t KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005; 331:1169.","DOI":"10.1136\/bmj.38623.768588.47"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009; 169:1952-1960.","DOI":"10.1001\/archinternmed.2009.357"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004; 57:6-14.","DOI":"10.1046\/j.1365-2125.2003.02007.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Watson NF, Benca RM, Krystal AD, McCall WV, Neubauer DN. Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia. J Clin Med. 2023; 12:2493.","DOI":"10.3390\/jcm12072493"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Palagini L, Brugnoli R, Osso BMD, Nicola MD, Maina G, Martinotti G, Maruani J, Mauries S, Serafini G, Mencacci C, Liguori C, Ferini-Strambi L, Geoffroy PA, Balestrieri M. Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: Results of European neuropsychopharmacology and sleep expert&apos;s consensus group. Sleep Med. 2025; 128:117-126.","DOI":"10.1016\/j.sleep.2025.01.033"},{"key":"10","unstructured":"10. Japanese Society of Sleep Research. Sleep Disorder Clinical Practice Guideline 2023. Tokyo, Japan; 2023. (in Japanese)"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ishimura A, Yabuki N. Nationwide Trends in Insomnia Medication Use Among Older Adults in Japan: NDB Open Data Analysis (2019\u20132023). BPB Reports. 2026; 9:48-51.","DOI":"10.1248\/bpbreports.9.2_48"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Horne R, Weinman J. Patients&apos; beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999; 47:555-567.","DOI":"10.1016\/S0022-3999(99)00057-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Horne R, Chapman SCE, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients&apos; adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013; 8:e80633.","DOI":"10.1371\/journal.pone.0080633"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tully IA, Kim JP, Simpson N, Palaniappan L, Tutek J, Gumport NB, Dietch JR, Manber R. Beliefs about prescription sleep medications and interest in reducing hypnotic use: an examination of middle-aged and older adults with insomnia disorder. J Clin Sleep Med. 2023; 19:1247-1257.","DOI":"10.5664\/jcsm.10552"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lee JY, Farrell B, Holbrook AM. Deprescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines. Pol Arch Intern Med. 2019; 129:43-49.","DOI":"10.20452\/pamw.4391"},{"key":"16","unstructured":"16. Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B. Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline. Can Fam Physician. 2018; 64:339-351."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. McCarthy M, Mak S, Kaufmann CN, Lum HD, Fung CH. Care coordination needs for deprescribing benzodiazepines and benzodiazepine receptor agonists. Res Social Adm Pharm. 2022; 18:2691-2694.","DOI":"10.1016\/j.sapharm.2021.06.025"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/advpub\/0\/advpub_2026.01065\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:39:29Z","timestamp":1792816769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/advpub\/0\/advpub_2026.01065\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":17,"URL":"https:\/\/doi.org\/10.5582\/ddt.2026.01065","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2026.01065"}}